Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Hee Sook | - |
dc.contributor.author | Kim, Hyosuk | - |
dc.contributor.author | Han, Geonhee | - |
dc.contributor.author | Lee, Jong Won | - |
dc.contributor.author | Kim, Kwangmeyung | - |
dc.contributor.author | Kwon, Ick Chan | - |
dc.contributor.author | Yang, Yoosoo | - |
dc.contributor.author | Kim, Sun Hwa | - |
dc.date.accessioned | 2022-03-01T05:42:10Z | - |
dc.date.available | 2022-03-01T05:42:10Z | - |
dc.date.created | 2022-02-09 | - |
dc.date.issued | 2021-06 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/137340 | - |
dc.description.abstract | Extracellular vesicles (EV) deliver cargoes such as nucleic acids, proteins, and lipids between cells and serve as an intercellular communicator. As it is revealed that most of the functions associated to EVs are closely related to the immune response, the important role of EVs in inflammatory diseases is emerging. EVs can be functionalized through EV surface engineering and endow targeting moiety that allows for the target specificity for therapeutic applications in inflammatory diseases. Moreover, engineered EVs are considered as promising nanoparticles to develop personalized therapeutic carriers. In this review, we highlight the role of EVs in various inflammatory diseases, the application of EV as anti-inflammatory therapeutics, and the current state of the art in EV engineering techniques. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | MESENCHYMAL STEM-CELLS | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | IMMUNE-RESPONSES | - |
dc.subject | LUNG INJURY | - |
dc.subject | EXOSOMES | - |
dc.subject | MICROPARTICLES | - |
dc.subject | DELIVERY | - |
dc.subject | NEUROINFLAMMATION | - |
dc.subject | MICROVESICLES | - |
dc.subject | RELEASE | - |
dc.title | Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Kwangmeyung | - |
dc.identifier.doi | 10.3390/ijms22115487 | - |
dc.identifier.scopusid | 2-s2.0-85106047733 | - |
dc.identifier.wosid | 000660163400001 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.22, no.11 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.volume | 22 | - |
dc.citation.number | 11 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | EXOSOMES | - |
dc.subject.keywordPlus | IMMUNE-RESPONSES | - |
dc.subject.keywordPlus | LUNG INJURY | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | MICROPARTICLES | - |
dc.subject.keywordPlus | MICROVESICLES | - |
dc.subject.keywordPlus | NEUROINFLAMMATION | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordAuthor | EV engineering | - |
dc.subject.keywordAuthor | biomarker | - |
dc.subject.keywordAuthor | extracellular vesicle | - |
dc.subject.keywordAuthor | inflammatory disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.